Extending the term of exclusive access to clinical trial data will raise drug costs in the short term but also help approve 200 extra drugs and result in greater life expectancy in the long term, ...

NEW YORK, Dec 4 (Reuters) - Global drugmaker Pfizer Inc will broaden access to information from its scores of clinical trials to independent researchers and to patients who take part in the studies, ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...

Revolutionary AI assistant RISA eliminates the pain of hunting for patient data across multiple systems, enabling clinicians to focus more on patient care ThetaRho.ai, a provider of AI-powered ...

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...

New functionality within Counterpart Assistant uses Google Cloud’s Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data WILMINGTON, Del., March 03, ...

Shares of Structure Therapeutics GPCR skyrocketed 102.5% after the company reported positive top-line data from the ACCESS ...

Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...